Intra-arterial chemotherapy for retinoblastoma can be highly successful in both treatment-naïve and non-naïve eyes.
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback